Clinicopathological significance of increased ZIC1 expression in human endometrial cancer

Abstract

Zinc finger of the cerebellum (ZIC1), one of ZIC family genes, has been shown to play important roles in many cancers such as gastric cancer and breast cancer. However, there is little known about the expression and significance of ZIC1 in endometrial cancer. The aim of this study was to determine the expression pattern and clinicopathological significance of ZIC1 in endometrial cancer. The mRNA and protein expression of ZIC1 in endometrial cancer tissues was detected using the reversetranscription polymerase chain reaction and Western blotting, respectively. Immunostaining of ZIC1 in 99 endometrial cancer samples was examined and its associations with clinicopathological parameters were analyzed. Hec-1-B cells were transfected with ZIC1-shRNA or sc-shRNA, and cell proliferation was assayed. Hec-1-B cells stably transfected with ZIC1-shRNA or sc-shRNA were subcutaneously inoculated into nude mice, and the tumor weight was measured. A significantly increased expression of ZIC1 mRNA and protein was observed in endometrial cancer tissues compared to that in normal endometrial tissues (P<0.05). Immunohistochemical analysis showed that strong cytoplasmic immunostaining of ZIC1 was observed in almost all endometrial cancer samples (90/99) while light and moderate immunostaining of ZIC1 was only detected in 17 of 30 (56.7%) normal tissues. Moreover, up-regulation of ZIC1 was significantly correlated with age, disease stage, TNM stage and FIGO stage (P<0.05). The down-regulated expression of ZIC1 contributed to the inhibition of cell proliferation, and inhibited the growth of tumor. It was concluded that ZIC1 is over-expressed in endometrial cancer tissue but not in normal tissue, and positively correlated to the malignant biological behavior of endometrial carcinogenesis.

Keywords

endometrial adenocarcinoma / zinc finger of the cerebellum / reverse transcription-polymerase chain reaction / immunohistochemistry

References

[1] ChervenakAP, BankLM, ThomsenN, et al. . The role of Zic genes in inner ear development in the mouse: Exploring mutant mouse phenotypes. Dev Dyn, 2014, 243(11): 1487-1498 PMCID: 4206579 PMID: 25178196

[2] ArugaJ, YokotaN, HashimotoM, et al. . A novel zinc finger protein, zic, is involved in neurogenesis, especially in the cell lineage of cerebellar granule cells. J Neurochem, 1994, 63(5): 1880-1890 PMID: 7931345

[3] MerzdorfCS. Emerging roles for zic genes in early development. Dev Dyn, 2007, 236(4): 922-940 PMID: 17330889

[4] BrillE, GobbleR, AngelesC, et al. . ZIC1 overexpression is oncogenic in liposarcoma. Cancer Res, 2010, 70(17): 6891-6901 PMCID: 3266950 PMID: 20713527

[5] PourebrahimR, Van DamK, BautersM, et al. . ZIC1 gene expression is controlled by DNA and histone methylation in mesenchymal proliferations. FEBS Lett, 2007, 581(26): 5122-5126 PMID: 17936758

[6] WangYY, JiangJX, MaH, et al. . Role of ZIC1 methylation in hepatocellular carcinoma and its clinical significance. Tumour Biol, 2014, 35(8): 7429-7433 PMID: 24782033

[7] YokotaN, ArugaJ, TakaiS, et al. . Predominant expression of human zic in cerebellar granule cell lineage and medulloblastoma. Cancer Res, 1996, 56(2): 377-383 PMID: 8542595

[8] JemalA, BrayF, CenterMM, et al. . Global cancer statistics. CA Cancer J Clin, 2011, 61(2): 69-90 PMID: 21296855

[9] Bakkum-GamezJN, Gonzalez-BosquetJ, LaackNN, et al. . Current issues in the management of endometrial cancer. Mayo Clin Proc, 2008, 83(1): 97-112 PMID: 18174012

[10] IlvanS, AkyildizEU, CalayZ, et al. . Endometrial clear cell carcinoma metastatic to the paranasal sinuses: a case report and review of the literature. Gynecol Oncol, 2004, 94(1): 232-234 PMID: 15262150

[11] AmantF, MoermanP, NevenP, et al. . Endometrial cancer. Lancet, 2005, 366(9484): 491-505 PMID: 16084259

[12] BrillE, GobbleR, AngelesC, et al. . ZIC1 is downregulated through promoter hypermethylation, and functions as a tumor suppressor gene in colorectal cancer. PLoS One, 2011, 6(2): 16916

[13] WangLJ, JinHC, WangX, et al. . ZIC1 is downregulated through promoter hypermethylation in gastric cancer. Biochem Biophys Res Commun, 2009, 379(4): 959-963 PMID: 19135984

[14] ArugaJ. The role of Zic genes in neural development. Mol Cell Neurosci, 2004, 26(2): 205-221 PMID: 15207846

[15] KallioniemiOP, WagnerU, KononenJ, et al. . Tissue microarray technology for high-throughput molecular profiling of cancer. Hum Mol Genet, 2001, 10(7): 657-662 PMID: 11257096

[16] KononenJ, BubendorfL, KallioniemiA, et al. . Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nat Med, 1998, 4(7): 844-847 PMID: 9662379

[17] LarsenI S M, JohannesenTB, et al. . Data quality at the Cancer Registry of Norway: an overview of comparability, completeness, validity and timeliness. Eur J Cancer, 2009, 45(7): 1218-1231 PMID: 19091545

[18] LindemannK, EskildA, VattenLJ, et al. . Endometrial cancer incidence trends in Norway during 1953–2007 and predictions for 2008–2027. Intern J Cancer, 2010, 127(11): 2661-2668

[19] SoroskyI, JoelI. Cáncer Endometrial. Obstet Gynecol, 2012, 120: 383-397 PMID: 22825101

[20] DongP, KaneuchiM, KonnoY, et al. . Emerging therapeutic biomarkers in endometrial cancer. Biomed Res Int, 2013, 2013: 130362 PMCID: 3693108 PMID: 23819113

[21] PratJ. Prognostic parameters of endometrial carcinoma. Human Pathol, 2004, 35(6): 649-662

[22] GrinbergI, MillenKJ. The ZIC gene family in development and disease. Clin Genet, 2005, 67(4): 290-296 PMID: 15733262

[23] BaeCJ, ParkBY, LeeYH, et al. . Identification of Pax3 and Zic1 targets in the developing neural crest. Genom Develop Control, 2014, 386(2): 473-483

[24] ZhongJ, ChenS, XueM, et al. . ZIC1 modulates cell-cycle distributions and cell migration through regulation of sonic hedgehog, PI(3)K and MAPK signaling pathways in gastric cancer. BMC Cancer, 2012, 12: 290 PMCID: 3411411 PMID: 22799764

[25] DenysH, JadidizadehA, NikSA, et al. . Identification of IGFBP-6 as a significantly downregulated gene by ß-catenin in desmoid tumors. Oncogene, 2004, 23(3): 654-664 PMID: 14737101